Skip to main content
. 2017 Oct 16;4:2333794X17736700. doi: 10.1177/2333794X17736700

(3) Laboratory Data.

At the Start of Treatment
Current
Thyroid Cancer (−) Thyroid Cancer (+) P Thyroid Cancer (−) Thyroid Cancer (+) P
WBC (/µL) 4276 4433 .496 5413 5766 .474
Lymphocytes (/µL) 1055 648 .371 957 1339 .092
Hb (g/dL) 11.1 10.4 .333 12.8 10.6 .0341
Plt (×104/µL) 16.7 22.4 .35 24 30.7 .112
Cre (mg/dL) 0.47 0.55 .266 1.41 0.48 .282
CH50 (U/mL) 22.1 7.0 .298 32.8 38.8 .618
C3 (mg/dL) 64.2 60.0 .616 84.2 86 .641
C4 (mg/dL) 11.4 11.0 .693 16.1 20.3 .37
CRP (mg/dL) 0.975 0.563 .519 0.098 0.423 .325
SAA (µg/mL) 167.5 226.4 .229 10.05 28.67 .146
ESR (mm/h) 47.1 68.0 .334 16.4 23 .926
ANA (fold) 1647 1493 .687 769 40 .243
Homogeneous type 15/26 1/3 .573 8/14 1/1 .243
Speckled type 19/26 2/3 1 12/14 1/1 1
Nucleolar type 1/26 0/3 1 0/14 0/1 1
Peripheral type 0/26 0/3 1 0/14 0/1 1
Centromere type 0/26 0/3 1 0/14 0/1 1
Granular type 0/26 0/3 1 1/14 0/1 1
Nuclearmembrane type 0/26 0/3 1 0/14 0/1 1
Anti-DNA Ab (IU/mL) 88.3 135.6 .709 10.23 6.33 .367
Anti-dsDNA IgG (IU/mL) 126.5 183.5 .876 8.73 6.07 .316
Anti-Sm Ab 15/22 2/3 1 6/22 0/3 .554
Anti-U1RNP Ab 6/18 2/3 1 2/20 0/3 1
Anti-SSA Ab 19/24 1/3 .156 17/23 1/3 .215
Anti-SSB Ab 8/23 1/3 1 6/23 0/3 1
Anti-cardiolipin Ab 13/22 2/3 1 3/13 2/2 .095
Lupus anti-coagulant 7/21 0/3 .53 3/12 0/1 1
BFP 0/4 0/1 1 0/0 0/0 1
Hemolytic anemia 1/25 0/3 1 0/26 0/3 .316
Proteinuria (mg/dL) 111 22.0 .139 3.14 11.8 .187
Hematuria 5/25 2/3 .145 1/25 0/3 1
Urine granular cast 1/25 2/3 .023 1/25 0/3 1

Abbreviations: WBC, white blood cells; Hb, hemoglobin; Plt, platelet; Cre, creatinine; CH50, 50% hemolytic complement; C3, complement component 3; C4, complement component 4; CRP, C-reactive protein; SAA, serum amyloid A; ESR, erythrocyte sedimentation rate; ANA, anti-nuclear antibody; Ab, antibody; BFP, biological false positive.